PL360397A1 - Wczesne diagnozowanie chorób konformacyjnych - Google Patents

Wczesne diagnozowanie chorób konformacyjnych

Info

Publication number
PL360397A1
PL360397A1 PL36039701A PL36039701A PL360397A1 PL 360397 A1 PL360397 A1 PL 360397A1 PL 36039701 A PL36039701 A PL 36039701A PL 36039701 A PL36039701 A PL 36039701A PL 360397 A1 PL360397 A1 PL 360397A1
Authority
PL
Poland
Prior art keywords
early diagnosis
conformational diseases
conformational
diseases
diagnosis
Prior art date
Application number
PL36039701A
Other languages
English (en)
Other versions
PL211154B1 (pl
Inventor
Claudio Soto
Gabriella Saborio
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of PL360397A1 publication Critical patent/PL360397A1/pl
Publication of PL211154B1 publication Critical patent/PL211154B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL360397A 2000-07-07 2001-06-13 Sposób diagnozowania lub wykrywania choroby konformacyjnej, sposób oznaczania markera choroby konformacyjnej oraz zestaw diagnostyczny do zastosowania w tym sposobie, sposób identyfikowania związku i sposób wykrywania chorobotwórczej formy białka PL211154B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (2)

Publication Number Publication Date
PL360397A1 true PL360397A1 (pl) 2004-09-06
PL211154B1 PL211154B1 (pl) 2012-04-30

Family

ID=27223071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360397A PL211154B1 (pl) 2000-07-07 2001-06-13 Sposób diagnozowania lub wykrywania choroby konformacyjnej, sposób oznaczania markera choroby konformacyjnej oraz zestaw diagnostyczny do zastosowania w tym sposobie, sposób identyfikowania związku i sposób wykrywania chorobotwórczej formy białka

Country Status (30)

Country Link
US (1) US7351526B2 (pl)
EP (2) EP1299729B1 (pl)
JP (1) JP4790966B2 (pl)
KR (1) KR100764981B1 (pl)
CN (1) CN1221807C (pl)
AR (1) AR029583A1 (pl)
AT (2) ATE426816T1 (pl)
AU (2) AU6408901A (pl)
BG (1) BG66272B1 (pl)
BR (1) BRPI0112262B8 (pl)
CA (1) CA2413078C (pl)
CY (1) CY1109106T1 (pl)
CZ (1) CZ304365B6 (pl)
DE (2) DE60121958T2 (pl)
DK (2) DK1712920T3 (pl)
EA (1) EA007391B1 (pl)
EE (1) EE05675B1 (pl)
ES (2) ES2322660T3 (pl)
HR (1) HRP20030033B1 (pl)
HU (1) HU228813B1 (pl)
IL (2) IL153824A0 (pl)
MX (1) MXPA03000226A (pl)
NO (1) NO331624B1 (pl)
NZ (1) NZ523213A (pl)
PL (1) PL211154B1 (pl)
PT (2) PT1299729E (pl)
RS (1) RS51523B (pl)
SI (2) SI1712920T1 (pl)
SK (1) SK287768B6 (pl)
WO (1) WO2002004954A2 (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002073210A1 (de) * 2001-03-13 2002-09-19 Manfred Eigen Verfahren zur verstärkung der bildung von aggregaten aus proteinuntereinheiten
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
EP1395833B1 (en) * 2001-05-31 2013-02-27 Adlyfe, Inc. Misfolded protein sensor method
JP5133561B2 (ja) * 2003-06-19 2013-01-30 メルク セローノ ソシエテ アノニム プリオン変換を調節する因子の使用
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
DE10328830A1 (de) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach asymmetrischer Interaktion
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases
NZ580256A (en) 2003-08-13 2011-07-29 Novartis Vaccines & Diagnostic Prion-specific peptide reagents comprising the sequence KKRPKPGG
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (ja) * 2004-12-28 2010-10-27 国立大学法人金沢大学 アルツハイマー病の検査方法
AU2006214463B2 (en) * 2005-02-15 2012-08-30 Presympto, Inc. Method for detecting misfolded proteins and prions
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
DE102005031429A1 (de) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
EP1931695B1 (en) 2005-09-09 2013-04-10 Novartis AG Prion-specific peptoid reagents
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
EP2156181B1 (en) 2006-07-28 2015-11-04 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
WO2008030973A2 (en) * 2006-09-06 2008-03-13 The Board Of Regents Of The University Of Texas System Methods and compositions for the detection of protein folding disorders
EP2554996B1 (en) * 2007-07-20 2016-04-06 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
EP2280028B1 (en) 2008-05-28 2013-03-27 Incorporated Administrative Agency National Agriculture and Food Research Organization Method for efficiently amplifying abnormal prion protein derived from sheep scrapie
CA2725100C (en) 2008-05-28 2014-02-18 Incorporated Administrative Agency National Agriculture And Food Research Organization Method for efficiently amplifying abnormal prion protein derived from bse
ITMI20081052A1 (it) * 2008-06-10 2009-12-11 Univ Milano Bicocca Liposomi in grado di legare efficacemente il peptide beta-amiloide
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
JP2013510297A (ja) * 2009-11-04 2013-03-21 ノバルティス アーゲー モノマーからのタンパク質凝集体の分離における結合試薬としての正に荷電した種
US9910049B2 (en) 2014-09-11 2018-03-06 Amprion, Inc. Detection of misfolded amyloid beta protein
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
IT1405762B1 (it) 2010-11-25 2014-01-24 Icgeb Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
EP2666020A1 (en) * 2011-01-18 2013-11-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods for amplification and detection of prions
FR2973114A1 (fr) 2011-03-21 2012-09-28 Ets Francais Du Sang Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
KR101483438B1 (ko) * 2014-04-17 2015-01-16 한림대학교 산학협력단 극미량 병원성 프리온 단백질 검출방법 및 장치
EP3191599B1 (en) 2014-09-11 2023-08-02 Board Of Regents Of the University Of Texas System Detection of misfolded proteins
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
TW201901153A (zh) 2017-05-16 2019-01-01 美商安培恩股份有限公司 折疊錯誤之ｔａｕ蛋白的檢測及檢測折疊錯誤之ｔａｕ蛋白的套組
US20190353669A1 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of Brain Injury or Neurological Disease using Tau Protein
CN120795059A (zh) 2018-08-27 2025-10-17 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample
CN120367833B (zh) * 2025-04-26 2026-02-24 浙江青霄科技股份有限公司 一种潜水泵

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
NZ335290A (en) * 1996-10-15 2001-08-31 D Gen Ltd Diagnosis an typing of spongiform encephalopathy (or bovine spongiform encephalopathy (BSE))
AU5778400A (en) * 1999-06-29 2001-01-31 Caprion Pharmaceuticals, Inc. Prion protein binding proteins and uses thereof
WO2001046714A1 (en) * 1999-12-10 2001-06-28 Misonix Incorporated Ultrasonic horn assembly
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
US7351526B2 (en) 2008-04-01
BRPI0112262B1 (pt) 2016-08-09
SI1712920T1 (sl) 2009-10-31
EP1712920B1 (en) 2009-03-25
ES2322660T3 (es) 2009-06-24
AU6408901A (en) 2002-01-21
WO2002004954A2 (en) 2002-01-17
HK1058065A1 (en) 2004-04-30
EE200300005A (et) 2004-08-16
EE05675B1 (et) 2013-08-15
CN1221807C (zh) 2005-10-05
JP2004503748A (ja) 2004-02-05
AU2001264089B2 (en) 2006-03-30
PT1712920E (pt) 2009-04-09
SK18582002A3 (sk) 2003-05-02
NO20030059L (no) 2003-03-07
CZ304365B6 (cs) 2014-04-02
WO2002004954A3 (en) 2002-10-24
HRP20030033B1 (hr) 2008-04-30
KR20030036257A (ko) 2003-05-09
BR0112262A (pt) 2003-05-20
BG107498A (bg) 2003-11-28
CZ200336A3 (cs) 2003-06-18
YU101202A (sh) 2006-01-16
IL153824A0 (en) 2003-07-31
BRPI0112262B8 (pt) 2021-07-27
MXPA03000226A (es) 2004-05-21
CA2413078C (en) 2010-08-03
NZ523213A (en) 2005-01-28
ATE426816T1 (de) 2009-04-15
CA2413078A1 (en) 2002-01-17
KR100764981B1 (ko) 2007-10-09
CN1449497A (zh) 2003-10-15
SI1299729T1 (sl) 2006-10-31
HU228813B1 (en) 2013-05-28
HRP20030033A2 (en) 2004-02-29
DK1712920T3 (da) 2009-05-11
PT1299729E (pt) 2006-10-31
HUP0301020A3 (en) 2010-03-29
EA200300126A1 (ru) 2003-06-26
CY1109106T1 (el) 2014-07-02
RS51523B (sr) 2011-06-30
ATE335204T1 (de) 2006-08-15
DE60121958T2 (de) 2007-02-01
AR029583A1 (es) 2003-07-02
EA007391B1 (ru) 2006-10-27
HUP0301020A2 (hu) 2003-07-28
NO331624B1 (no) 2012-02-06
DE60121958D1 (de) 2006-09-14
NO20030059D0 (no) 2003-01-06
US20050064505A1 (en) 2005-03-24
EP1299729A2 (en) 2003-04-09
PL211154B1 (pl) 2012-04-30
DE60138146D1 (de) 2009-05-07
BG66272B1 (bg) 2012-11-30
JP4790966B2 (ja) 2011-10-12
DK1299729T3 (da) 2006-12-04
EP1299729B1 (en) 2006-08-02
EP1712920A1 (en) 2006-10-18
SK287768B6 (sk) 2011-09-05
ES2264691T3 (es) 2007-01-16
IL153824A (en) 2010-02-17

Similar Documents

Publication Publication Date Title
AU6408901A (en) Early diagnosis of conformational diseases
AU2001289617A1 (en) Diagnosis of diseases associated with signal transduction
PL362711A1 (pl) Pochodne morfolinoacetamidu do leczenia chorób zapalnych
HUP0401127A3 (en) Treatment and diagnosis of macrophage disease
PL367311A1 (pl) Podstawione ugrupowaniami chinuklidyny wielopierścieniowe związki heteroarylowe do leczenia chorób
GB0015745D0 (en) Treatment of bone diseases
AU7863201A (en) Treatment of hyperproliferative diseases
GB0320238D0 (en) Treatment of disease
GB0016392D0 (en) Skin diagnostic aid
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
IL141950A0 (en) Diagnosis of prion diseases
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
EP1411985A4 (en) TREATMENT OF PARASITICAL DISEASES
AU2003282878A8 (en) Diagnosis of invasive mold infection
AU4962001A (en) Diagnosis of autoimmune disease
AU2001253024A1 (en) Diagnosis and treatment of gastrointestinal disease
IL139185A0 (en) Diagnosis of prion diseases
AU2003295504A8 (en) Development of therapeutics for the treatment of endotoxin-mediated diseases
AU2002350975A8 (en) Diagnosis of inflammatory bowel disease
GB0001116D0 (en) Diagnosis of toxicoinfectious clostridiosis
AU2003234488A8 (en) Diagnosis of glaucoma
AU1324002A (en) Treatment of demyelinating diseases
GB9919565D0 (en) Treatment of disease
GB9915881D0 (en) Methods of diagnosis
AU2002365654A8 (en) Treatment of diseases via the skin